Understanding how T-bet helps the immune system fight Toxoplasma gondii infections
T-bet-regulated myeloid innate defense against Toxoplasma gondii
This study is looking at how a protein called T-bet helps our immune system fight off a parasite that can cause serious problems, especially for pregnant women and people with weakened immune systems, to find better ways to treat those affected by this infection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10873064 on NIH RePORTER |
What this research studies
This research investigates the role of a specific protein called T-bet in the immune response against Toxoplasma gondii, a parasite that can cause serious health issues, especially in pregnant women and immunocompromised individuals. The study aims to explore how T-bet influences myeloid cells, which are crucial for fighting off this infection. By examining the immune mechanisms involved, the research seeks to identify new therapeutic strategies that could improve treatment options for those affected by toxoplasmosis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are pregnant or immunocompromised and at risk of severe complications from Toxoplasma gondii infection.
Not a fit: Patients who are not at risk for Toxoplasma gondii infection or those with mild cases may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and safer treatments for toxoplasmosis, reducing complications for patients.
How similar studies have performed: Previous research has shown promising results in understanding immune responses to Toxoplasma gondii, but the specific role of T-bet in this context is still being explored.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Lopez-Yglesias, Americo Harry — Indiana University Indianapolis
- Study coordinator: Lopez-Yglesias, Americo Harry
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.